☰

Hanyin Cheng, Ph.D. - Publications

Affiliations: 
2007 The University of Texas Graduate School of Biomedical Sciences at Houston 
Area:
Cell Biology
Tree Info Grants Similar researchers PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Cheng H, Dharmadhikari AV, Varland S, Ma N, Domingo D, Kleyner R, Rope AF, Yoon M, Stray-Pedersen A, Posey JE, Crews SR, Eldomery MK, Akdemir ZC, Lewis AM, Sutton VR, et al. Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies. American Journal of Human Genetics. PMID 29656860 DOI: 10.1016/J.Ajhg.2018.03.004  0.303
2018 Ohara M, Saito K, Kageyama K, Terai M, Cheng H, Aplin AE, Sato T. Abstract 2301: Dual targeting of CDK4/6 and MET in metastatic uveal melanoma Cancer Research. 78: 2301-2301. DOI: 10.1158/1538-7445.Am2018-2301  0.416
2017 Cheng H, Chua V, Liao C, Purwin TJ, Terai M, Kageyama K, Davies MA, Sato T, Aplin AE. Co-targeting HGF-cMET signaling with MEK inhibitors in metastatic uveal melanoma. Molecular Cancer Therapeutics. PMID 28138035 DOI: 10.1158/1535-7163.Mct-16-0552  0.438
2016 Cheng H, Kageyama K, Purwin T, Liao C, Terai M, Sato T, Aplin A. Abstract 4664: Co-targeting HGF-cMET signaling with MEK inhibitors in metastatic uveal melanoma Cancer Research. 76: 4664-4664. DOI: 10.1158/1538-7445.Am2016-4664  0.363
2015 Cheng H, Terai M, Kageyama K, Ozaki S, McCue PA, Sato T, Aplin AE. Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma. Cancer Research. 75: 2737-48. PMID 25952648 DOI: 10.1158/0008-5472.Can-15-0370  0.371
2015 Shao Y, Le K, Cheng H, Aplin AE. NF-κB Regulation of c-FLIP Promotes TNFα-Mediated RAF Inhibitor Resistance in Melanoma. The Journal of Investigative Dermatology. 135: 1839-48. PMID 25751672 DOI: 10.1038/Jid.2015.91  0.395
2015 Cheng H, Terai M, Sato T, Aplin A. Abstract 2685: Paracrine effect of NRG1 and HGF drives resistance to MEK inhibitors in metastatic uveal melanoma Cancer Research. 75: 2685-2685. DOI: 10.1158/1538-7445.Am2015-2685  0.406
2010 Lee AJ, Wu X, Cheng H, Zhou X, Cheng X, Sun SC. CARMA1 regulation of regulatory T cell development involves modulation of interleukin-2 receptor signaling. The Journal of Biological Chemistry. 285: 15696-703. PMID 20233721 DOI: 10.1074/Jbc.M109.095190  0.415
2010 Ross JA, Cheng H, Nagy ZS, Frost JA, Kirken RA. Protein phosphatase 2A regulates interleukin-2 receptor complex formation and JAK3/STAT5 activation. The Journal of Biological Chemistry. 285: 3582-91. PMID 19923221 DOI: 10.1074/Jbc.M109.053843  0.582
2008 Cheng H, Ross JA, Frost JA, Kirken RA. Phosphorylation of human Jak3 at tyrosines 904 and 939 positively regulates its activity. Molecular and Cellular Biology. 28: 2271-82. PMID 18250158 DOI: 10.1128/Mcb.01789-07  0.596
2007 Ross JA, Nagy ZS, Cheng H, Stepkowski SM, Kirken RA. Regulation of T cell homeostasis by JAKs and STATs. Archivum Immunologiae Et Therapiae Experimentalis. 55: 231-45. PMID 17659375 DOI: 10.1007/S00005-007-0030-X  0.624
2004 Nagy ZS, Ross J, Cheng H, Stepkowski SM, Kirken RA. Regulation of lymphoid cell apoptosis by Jaks and Stats. Critical Reviews in Immunology. 24: 87-110. PMID 15581392 DOI: 10.1615/Critrevimmunol.V24.I2.10  0.619
Show low-probability matches.